Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Hemodialysis: early-phase trial registry
5 of 13 indexed Hemodialysis trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #1,315 of 28,707 conditions by registered trial count.
13 US clinical trials · 5 currently recruiting · #1,315 of 28,707 conditions by registered trial count
Hemodialysis: 13 US clinical trials tracked, 5 recruiting.
Hemodialysis is the subject of 13 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Cara Therapeutics, running 1 of these trials.
Enrollment posture brief
Registry condition hemodialysis
OPEN 5 | RECR 38% | LATE 1 | EARLY 3 | RANK #1315 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Anaplastic Oligodendroglioma (38% recruiting · 13 trials)
Hemodialysis lists 5 open slots (38% of 13 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Hemodialysis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Hemodialysis is recruiting below its size-band peers.
5 of 13 indexed trials (38.5%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Hemodialysis trials is spread across many organizations.
Cara Therapeutics accounts for 1 of 13 trials (7.7%). 13 distinct sponsors appear on at least one study for this condition label.
-
Most Hemodialysis trials plan to enrol fewer than 100 people.
Median target enrolment is 62 among the 13 trials that report a genuine target (sentinel values excluded). 8 of those (61.5%) plan for fewer than 100 participants.
-
Hemodialysis research is mostly interventional.
11 interventional and 2 observational studies make up this index (84.6% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
13 total, page 1 of 1
A Randomized Controlled Trial of Thyroid Hormone Supplementation in Hemodialysis Patients
University of California, Irvine
NCT03977207
A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease
W.L.Gore & Associates
NCT04671771
Angiotensin-Neprilysin Inhibition in Hemodialysis Initiation
Brigham and Women's Hospital
NCT05498181
Contactless Optical Monitoring of AV Access Using the PatenSee System in Outpatient Hemodialysis Patients
PatenSee
NCT07194395
Physical Activity Prescription Program for Hemodialysis Patients
University of Arizona
NCT06830993
Trial to Evaluate and Assess the Effect of Comprehensive Pre-ESKD Education on Home Dialysis Use in Veterans
VA Office of Research and Development
NCT04064086
Improving Blood Pressure Control in End-Stage Renal Disease Through a Supportive-Educative Nursing Intervention
Wayne State University
NCT01052220
Safety, Tolerability, and Feasibility of Empagliflozin Therapy in Dialysis-dependent ESKD
University of Utah
NCT05614115
Efficacy of Twice Weekly Hemodialysis in Patients With Residual Kidney Function
Palo Alto Veterans Institute for Research
NCT03874117
Comparison of Different Glucose Concentrations in Dialysate of Hemodialysis Patients
Renal Research Institute
NCT00618033
Measuring Cardiovascular Stress in Patients on Hemodialysis
West Penn Allegheny Health System
NCT01267617
Study to Evaluate the Pharmacokinetics and Metabolism of [14C] CR845 (Difelikefalin) in Patients With End Stage Renal Disease on Hemodialysis and in Healthy Subjects
Cara Therapeutics
NCT03947970
Administration of Zepatier (Grazoprevir Plus Elbasvir) in Chronic Hemodialysis (HD) Patients With Hepatitis C
University of Pennsylvania
NCT03365635
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 1 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Hemodialysis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Hemodialysis trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Hemodialysis page
13 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 5 Hemodialysis trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Cara Therapeutics sponsors the most Hemodialysis trials on record, review their full trial history before evaluating a specific study. See Cara Therapeutics's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Hemodialysis condition card totals 13 registered trials; most-linked intervention [14C] CR845; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.